Literature DB >> 23368647

Frequency of MYO9B polymorphisms in celiac patients and controls.

Tamara Loeff1, Magdalena Araya, Francisco Pérez-Bravo.   

Abstract

INTRODUCTION: the MYO9B gene contributes to the maintenance of the intestinal barrier and it has been postulated as a risk factor of celiac disease (CD). The objective of this study was to compare the frequency and association rs2305764, rs2305767 and rs1457092 MYO09B polymorphisms in pediatric CD patients from and. PATIENTS AND METHODS: the study was made in 104 CD pediatric patients (Chilean and Argentineans) and 104 controls subjects. MYO9B gene polymorphisms were analyzed by Taqman allelic probes. We evaluated the Hardy-Weinberg equilibrium by means of Chi-square and compared the haplotypes distribution using Fisher test.
RESULTS: SNPs rs2305767 and rs1457092 were associated with celiac disease (CD); TT genotype in rs2305767 would be a protective factor (p < 0.000, OR = 0.19 CI 0.1-0.4) and the CT genotype would be a risk factor (p < 0.0001, OR = 4.9 CI 2.2 to 11.3). CC genotype in rs1457092 also showed a protective effect for celiac (p < 0.000, OR = 0.07 CI 0.0 to 0.3).
CONCLUSION: our findings suggest that genetic variation MYO9B gene is associated with CD, as a protective or a risk factor depending on the polymorphism studied.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23368647     DOI: 10.4321/s1130-01082012001100003

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  4 in total

1.  Association between the MYO9B polymorphisms and celiac disease risk: a meta-analysis.

Authors:  Ning Liao; Min-Li Chen; Hua Zhao; Zheng-Fu Xie
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Celiac disease: a comprehensive current review.

Authors:  Giacomo Caio; Umberto Volta; Anna Sapone; Daniel A Leffler; Roberto De Giorgio; Carlo Catassi; Alessio Fasano
Journal:  BMC Med       Date:  2019-07-23       Impact factor: 8.775

3.  Individual variability in patterns and dynamics of fecal gluten immunogenic peptides excretion after low gluten intake.

Authors:  Laura Coto; Carolina Sousa; Angel Cebolla
Journal:  Eur J Nutr       Date:  2022-01-07       Impact factor: 4.865

Review 4.  Pancreatic Involvement in Pediatric Inflammatory Bowel Disease.

Authors:  Javier Martín-de-Carpi; Melinda Moriczi; Gemma Pujol-Muncunill; Victor M Navas-López
Journal:  Front Pediatr       Date:  2017-10-11       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.